Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Can LAA be performed at the same time as ablation? Can patients with previous valve surgery or ASD safely undergo LAA? When to be concerned with a leak? Drs. Oussama Wazni, Walid Saliba, Mohamed Kanj, and Tyler Taigen discuss considerations for left atrial appendage closure.

Calcium metabolism has long been implicated in aortic stenosis. Dr. Samir Kapadia and Dr. Nicholas Kassis discuss supplemental calcium, both with and without vitamin D, and it how it relates to aortic stenosis, need for aortic valve replacement, and mortality.

Tamanna Singh, MD discusses sports cardiology and return to play considerations.

There have been many advancements in the field of electrophysiology. Dr. Oussama Wazni, Section Head, Cardiac Electrophysiology & Pacing Section, and Dr. Hiroshi Nakagawa discuss some of these evolutions and progress including new methods utilizing ablation index, ablation techniques, and developments in advanced high-definition mapping.

You may have heard this expression “Exercise is medicine” and wondered if it is true. Dr. Michael Emery explains that it is! The hardest part is getting started but Dr. Emery gives some helpful tips to get started and stick with it. Find what you enjoy doing and then find others who share in that passion to help you reach your goals.

Eric E. Roselli, MD provides an overview of the recent online session titled "Cutting-Edge Care for HyperAcute Proximal Aortic Dissection

Access to medical providers can be a challenge for many patients. Steven Nissen, MD, Cleveland Clinic Heart, Vascular & Thoracic Institute Chief Academic Officer, describes one approach to help improve patient access to nonprescription statin therapy. Technology-assisted self-selection showed to be an effect method of screening patients compared to clinician screening.

Tamanna Singh, MD and Adriano Tonelli, MD discuss non-invasive and invasive cardiopulmonary exercise testing.

Presented at the American College of Cardiology as a Late-Breaking Clinical Trial, the Cleveland Clinic-led APOLLO trial explores siRNA therapy as a treatment option to help prevent premature heart disease in people with high levels of Lp(a). This condition is estimated to affect 64 million people in the United States and 1.4 billion people worldwide. It is estimated that nearly 20 to 25% of the world’s population has elevated Lp(a). Dr. Steven Nissen, M.D., Chief Academic Officer of the Heart, Vascular & Thoracic Institute at Cleveland Clinic explains the purpose, patient selection, and findings of APOLLO.

Dr. Sagar Kalahasti provides an overview of novel advances in the treatment of aortitis.